Glenview Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corteva
CTVA
|
+$58.6M |
| 2 |
Alight
ALIT
|
+$58M |
| 3 |
Amazon
AMZN
|
+$43.9M |
| 4 |
Cencora
COR
|
+$43.4M |
| 5 |
Avantor
AVTR
|
+$42.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baxter International
BAX
|
+$102M |
| 2 |
Tenet Healthcare
THC
|
+$90.5M |
| 3 |
Meta Platforms (Facebook)
META
|
+$63.3M |
| 4 |
GTM
ZoomInfo Technologies
GTM
|
+$52.6M |
| 5 |
Flex
FLEX
|
+$48.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.17% |
| 2 | Technology | 20.62% |
| 3 | Miscellaneous | 11.18% |
| 4 | Industrials | 9.67% |
| 5 | Consumer Discretionary | 7.96% |
Similar funds
Glenview Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Glenview Capital Management held 68 positions worth $4.56B, up 0.98% from $4.51B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Glenview Capital Management withdrew a net $233M in Q1 2023, closing 14 positions and reducing 18 holdings. Its most notable exit was Baxter International, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 39% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Glenview Capital Management opened a new position in Amazon worth $47M.
- Glenview Capital Management's largest Q1 2023 buy was Amazon: 454,718 shares worth $47M.
- Glenview Capital Management added most to Corteva in Q1 2023, an estimated $58.6M increase.
- Glenview Capital Management's biggest Q1 2023 reduction was Tenet Healthcare, cutting an estimated $90.5M.
- Glenview Capital Management fully exited Baxter International in Q1 2023, selling an estimated $102M.
- Glenview Capital Management's ten largest holdings make up 60% of its $4.56B portfolio in Q1 2023.
- Glenview Capital Management opened 14 new positions and closed 14 in Q1 2023.
- Glenview Capital Management's portfolio value rose 0.98% quarter-over-quarter to $4.56B.
Based on Glenview Capital Management's 13F filing for Q1 2023, filed 15 May 2023.